NPCE enters 2026 with rising RNS adoption, stronger margins and Medicare payment hikes that could boost hospital economics for replacement procedures.

First patient receives brain-responsive neuromodulation for LGS, a severe and disabling childhood-onset epilepsy MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- NeuroPace, Inc. (Nasdaq: NPCE), a ...

NPCE heads into 2026 with 20%+ RNS growth targets, higher Medicare reimbursement and a cleaner revenue mix as the DIXI distribution business rolls off.

NeuroPace, Inc., a medical device company focused on improving the lives of individuals with epilepsy, has announced that an abstract from its Post-approval Study of the RNS System will be presented ...

NeuroPace, Inc. (NASDAQ:NPCE) released preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for drug-resistant idiopathic ...

Shares of NeuroPace (NASDAQ:NPCE) shed ~24% in the premarket on Tuesday after the MedTech said that its NAUTILUS study evaluating its neuromodulation therapy RNS System failed to reach the primary ...

-- Submission supported by positive preliminary 18-month NAUTILUS data in patients with drug-resistant idiopathic generalized epilepsy (IGE) and generalized tonic-clonic (GTC) seizures -- The PMA-S is ...

NeuroPace NPCE recently announced promising preliminary one-year results from its pivotal NAUTILUS trial, evaluating the RNS System in patients with idiopathic generalized epilepsy (IGE). This study ...

First of its kind, multi-year collaboration leverages RNS System’s data to track responses of implanted RNS System patients enrolled in a biotechnology company’s clinical trial In strategic data ...

--CY 2026 Outpatient Prospective Payment System (OPPS) Final Rule moves RNS replacement procedures to highest-paying neurostimulator APC-- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today announced that the first patient was ...

A University of Alabama at Birmingham pediatric neurosurgeon has performed the first deep brain stimulation (DBS) procedure for epilepsy at Children’s of Alabama (COA), offering a new treatment option ...